AUTHOR NAME

AJ

297 POSTS
0 COMMENTS

Takeda Presents Positive Phase 2b Study Results for Mezagitamab (TAK-079) in Treating Primary Immune Thrombocytopenia (ITP)

Takeda today announced positive findings from its Phase 2b, randomized, double-blind, placebo-controlled trial evaluating the safety, tolerability, and efficacy of mezagitamab (TAK-079) in patients...

Brenus Pharma Presents Study Design for “BreAK-CRC” at ASCO Annual Meeting

Brenus Pharma, a French biotech company developing the innovative “Stimulated-Tumor-Cell” (STC) discovery platform, has unveiled the study design for its first-in-human trial, “BreAK-CRC,” featuring...

Marea Therapeutics Launches with $190 Million in Funding to Revolutionize Cardiometabolic Disease Treatment

Marea Therapeutics, a clinical-stage biotechnology company incubated by Third Rock Ventures, has officially launched with a combined $190 million from Series A and B...

Alphawave Semi Announces Successful Tape-Out of Industry’s First Off-the-Shelf Multi-Protocol I/O Connectivity Chiplet on TSMC’s 7nm Process

Alphawave Semi (LSE: AWE), a global leader in high-speed connectivity and compute silicon, proudly announces the successful tape-out of the industry’s first off-the-shelf multi-protocol...

Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced compelling results from its Phase III STARGLO study of Columvi®...

Sparrow Pharmaceuticals Presents Data from Ongoing Phase 2 Trial of Clofutriben (SPI-62) and Prednisolone as a Treatment for Polymyalgia Rheumatica at EULAR 2024

Sparrow Pharmaceuticals has announced new data from an ongoing Phase 2 clinical trial of HSD-1 inhibitor clofutriben (SPI-62) and prednisolone in patients with polymyalgia...

Sibylla’s PPI-FIT and MD Anderson Collaborate to Develop Cancer Therapies

Sibylla Biotech and The University of Texas MD Anderson Cancer Center have entered into a strategic collaboration to develop novel small-molecule cancer therapies called...

Advancing Understanding of Idiopathic Pulmonary Fibrosis through Bayesian Network Analysis

A recent study has made significant strides in unraveling the complex molecular mechanisms underlying idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by...

Supercomputing Advances Drive In-Silico Drug Discovery for SARS-CoV-2

In a groundbreaking study, researchers have developed a supercomputer-driven pipeline for in-silico drug discovery, leveraging enhanced sampling molecular dynamics (MD) and ensemble docking techniques....

Identifying a Therapeutic Target for Multiple Sclerosis Using a Novel Method for Studying Astrocytes

Iain C. Clark and colleagues recently published an article in Nature that describes a new method for studying astrocytes, a type of cell that...

Latest news